News Focus
News Focus
Post# of 257308
Next 10
Followers 843
Posts 122821
Boards Moderated 10
Alias Born 09/05/2002

Re: jbog post# 202985

Friday, 07/29/2016 2:40:08 PM

Friday, July 29, 2016 2:40:08 PM

Post# of 257308
Not at all. Viekira is likely to strongly outsell Zepatier in Europe, given the preponderance of GT1b patients there.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today